Shelter Pharma H1 FY27 Results: Revenue Up 35.6% YoY, Eyes Capacity Doubling
Shelter Pharma Ltd · Outcome · 07 Nov 2026, 11:06 pm
Shelter Pharma H1 FY27 Results: Revenue Up 35.6% YoY, Eyes Capacity Doubling Shelter Pharma reported strong standalone H1 FY27 results, with revenue rising 35.6% YoY to Rs 451.3 mn and PAT increasing 15.4% YoY to Rs 51.9 mn. EBITDA grew 17.9% YoY to Rs 73.8 mn, though EBITDA margins contracted 244 bps YoY to 16.4% due to elevated freight and manpower costs. The company remains virtually debt-free with net debt-to-equity at 0.03x. Management guided for 35–40% revenue growth in FY27 and plans a Rs 120–150 mn capex to double revenue capacity beyond Rs 2,000 mn by 2028.
Original exchange filing (PDF)
More announcements from Shelter Pharma Ltd
- Attached herewith Statement of Deviation for quarter ended 30th September, 2026 · 07 Nov 2026
- Attached herewith Financial Results for Half year ended 30th September, 2026 · 07 Nov 2026
- Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) .... · 07 Nov 2026
- Attached here with order updates recieved on 28.10.2026 · 30 Oct 2026
- Conversion of Warrants into Equity Shares · 16 Oct 2026
- Outcome of the Board Meeting held on Friday, October 16, 2026 for conversion of warrants into Equity Shares · 16 Oct 2026
- Attached herewith Intimation for Regularization of Ms. Vinita Gadhavi as Non Executive Independent Director of the Company. · 30 Sept 2026
- Attached herewith Voting Results along with Scrutinizer Report of Shelter Pharma Limited · 30 Sept 2026
